-
PUBLICATION
Drug efficacy studies in NASH mouse modelNEW!!
2022.05.23
We would like to introduce a study published by our client using our proprietary non-alcoholic steatohepatitis (NASH) model called STAM™ (Ikewaki et al., bioRxiv, 2021).
-
PRODUCTS AND SERVICES
Introducing our new model: DDC-induced liver injury model
2022.05.10
We introduce the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced liver injury model*, a well-known model of cholestatic liver disease and a new model we have started offering our services as.
-
UPCOMING EVENTS
Reserve a non-clinical pharmacology consultation with us at BIO KOREA 2022!
2022.04.29
We will join BIO KOREA 2022 International Convention, one of the biggest bio-health conventions in Asia.